A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

Summary

This is a phase 1 open label, 4 treatment, 4 sequence and 4 period crossover study in subjects with solid tumours no longer responding to, or eligible for standard therapies, and for whom there are no additional standard therapies likely to benefit the subject.

Timeline

Start

2018-05-16

Primary completion

2019-03-12

Completion

2020-07-01

Drugs

Indications